Spinal Cord Stimulation for Pain
Trial Summary
What is the purpose of this trial?
To characterize the effects of stimulation parameters on pain relief and other cohort specific outcomes.
Eligibility Criteria
This trial is for adults over 22 with limb or back pain, who have had a Medtronic rechargeable neurostimulation system implanted for at least one month. Participants must understand English, be able to follow the study's procedures and document their experience. Pregnant women or those not using birth control are excluded.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive spinal cord stimulation with various programming settings to assess pain relief
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Spinal Cord Stimulation
Spinal Cord Stimulation is already approved in United States, European Union, Canada for the following indications:
- Failed back surgery syndrome (FBSS)
- Adhesive arachnoiditis
- Peripheral causalgia/neuropathy
- Reflex sympathetic dystrophy (RSD)
- Phantom limb/stump pain
- Ischemic pain of vascular origin
- Complex regional pain syndrome
- Pain after an amputation
- Visceral abdominal pain and perineal pain
- Chronic pain
- Neuropathic pain
- Spinal cord injury pain
- Failed back surgery syndrome (FBSS)
- Adhesive arachnoiditis
- Peripheral causalgia/neuropathy
- Reflex sympathetic dystrophy (RSD)
- Chronic pain
- Neuropathic pain
- Spinal cord injury pain
- Failed back surgery syndrome (FBSS)
- Adhesive arachnoiditis
- Peripheral causalgia/neuropathy
- Reflex sympathetic dystrophy (RSD)
Find a Clinic Near You
Who Is Running the Clinical Trial?
MedtronicNeuro
Lead Sponsor
Geoff Martha
MedtronicNeuro
Chief Executive Officer since 2020
Finance degree from Penn State University
Dr. Eric Peterson
MedtronicNeuro
Chief Medical Officer since 2020
MD from University of Miami